Summary & Overview
CPT 51570: Radical Cystectomy, Complete Urinary Bladder Removal
CPT code 51570 represents radical cystectomy — the surgical removal of the complete urinary bladder — most commonly performed for bladder cancer. This high-acuity, resource-intensive inpatient surgical procedure has significant implications for hospital capacity, perioperative care, and oncology care pathways nationally. Payment and utilization for radical cystectomy affect hospital surgical revenue, bundled payment models, and quality reporting for oncologic surgery.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context, typical sites of service, common billing modifiers and claims considerations, and comparisons of payer coverage behaviors where available. The publication summarizes typical reimbursement and coding practice considerations, highlights common billing complexities for major oncologic surgery, and outlines which benchmarks and policy updates are most likely to affect billing for CPT code 51570.
This summary is intended for billing managers, hospital revenue cycle leaders, clinical coders, and policy analysts seeking a concise national overview of coding and payer considerations for radical cystectomy. Data not available in the input will be noted in the detailed sections.
Billing Code Overview
CPT code 51570 describes the surgical removal of the complete urinary bladder (radical cystectomy). This procedure is most often performed to treat bladder cancer and involves removal of the bladder with or without adjacent structures depending on clinical indications.
-
Service type: Surgical procedure — major abdominal/pelvic oncologic surgery
-
Typical site of service: Inpatient hospital operating room with postoperative inpatient stay
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old male with muscle-invasive urothelial carcinoma of the bladder presenting with gross hematuria, irritative voiding symptoms, and a bladder mass seen on cystoscopy with biopsy confirming high-grade invasive disease. After staging studies including CT chest/abdomen/pelvis showing no distant metastases and multidisciplinary tumor board review, the patient is scheduled for a radical cystectomy with pelvic lymph node dissection and urinary diversion. The clinical workflow includes preoperative optimization (labs, cross-match, anesthesia evaluation), informed consent detailing cystectomy and possible urinary diversion types (ileal conduit, neobladder, or continent reservoir), bowel preparation if indicated, administration of prophylactic antibiotics and venous thromboembolism prophylaxis, intraoperative performance of a complete bladder extirpation (51570) with hemostasis and lymphadenectomy, creation of the chosen urinary diversion, placement of drains and catheters, and postoperative monitoring in a surgical unit with attention to fluid balance, pain control, early ambulation, and surveillance for complications such as infection, bleeding, and anastomotic leak. Hospital coding for the operative episode centers on 51570 to report the complete removal of the urinary bladder; additional procedure codes capture the lymph node dissection and the urinary diversion as applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|